News
22h
TipRanks on MSNRegeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment
The ongoing study could significantly impact the stock performance of Regeneron and Sanofi, as successful results may enhance their market position and investor confidence. The development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results